HUP0104254A2 - Ezrin szabályozó/kihajtogató peptidek - Google Patents

Ezrin szabályozó/kihajtogató peptidek

Info

Publication number
HUP0104254A2
HUP0104254A2 HU0104254A HUP0104254A HUP0104254A2 HU P0104254 A2 HUP0104254 A2 HU P0104254A2 HU 0104254 A HU0104254 A HU 0104254A HU P0104254 A HUP0104254 A HU P0104254A HU P0104254 A2 HUP0104254 A2 HU P0104254A2
Authority
HU
Hungary
Prior art keywords
peptides
ezrin
regulatory
hepreceptor
acid sequence
Prior art date
Application number
HU0104254A
Other languages
English (en)
Inventor
Rupert Donald Holms
Original Assignee
Rupert Donald Holms
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rupert Donald Holms filed Critical Rupert Donald Holms
Publication of HUP0104254A2 publication Critical patent/HUP0104254A2/hu
Publication of HUP0104254A3 publication Critical patent/HUP0104254A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A tal lm ny t rgy t olyan t"ltéssel rendelkező molekul k képezik,amelyek képesek a Hepreceptorhoz k"tődni, és a Hepreceptor egyrészével azonos aminosav szekvenci val rendelkeznek. A tal lm nykül"n"sen olyan peptidekre vonatkozik, amelyek 5-13 aminosav hosszúakés a Hepreceptor A és B doménjeinekegy részével azonos aminosavszekvenci val rendelkeznek. A tal lm ny szerinti peptidek felhasznlhatók fertőző betegségek és r k kezelésére immunv lasz induk l sa útjn. Ó
HU0104254A 1999-09-17 2000-09-15 Regulatory/unfolding peptides of ezrin HUP0104254A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9921881A GB2354241A (en) 1999-09-17 1999-09-17 Regulatory/unfolding peptides of ezrin
PCT/GB2000/003566 WO2001025275A1 (en) 1999-09-17 2000-09-15 Regulatory/unfolding peptides of ezrin

Publications (2)

Publication Number Publication Date
HUP0104254A2 true HUP0104254A2 (hu) 2002-04-29
HUP0104254A3 HUP0104254A3 (en) 2002-05-28

Family

ID=10861009

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104254A HUP0104254A3 (en) 1999-09-17 2000-09-15 Regulatory/unfolding peptides of ezrin

Country Status (23)

Country Link
US (1) US6849596B1 (hu)
EP (2) EP1131348B1 (hu)
JP (1) JP2003511389A (hu)
KR (1) KR20010101017A (hu)
CN (1) CN100387619C (hu)
AT (1) ATE356144T1 (hu)
AU (1) AU770208B2 (hu)
BR (1) BR0007158A (hu)
CA (1) CA2348780A1 (hu)
CY (1) CY1106644T1 (hu)
CZ (1) CZ20011689A3 (hu)
DE (1) DE60033783T2 (hu)
DK (1) DK1131348T3 (hu)
ES (1) ES2283317T3 (hu)
GB (1) GB2354241A (hu)
HU (1) HUP0104254A3 (hu)
NO (1) NO20012417L (hu)
NZ (1) NZ511747A (hu)
PL (1) PL348635A1 (hu)
PT (1) PT1131348E (hu)
RU (1) RU2215005C2 (hu)
WO (1) WO2001025275A1 (hu)
ZA (1) ZA200103938B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0301879D0 (en) * 2003-01-27 2003-02-26 Regent Res Llp HCV combination therapy
WO2007060440A2 (en) * 2005-11-23 2007-05-31 Regent Research L.L.P. The use of peptides in anti-ulcer therapy
CN100455665C (zh) * 2006-11-21 2009-01-28 汕头大学医学院 人食管癌细胞ezrin基因上游转录调控元件
WO2009103312A1 (en) * 2008-02-19 2009-08-27 Ludwig-Maximilians-Universität Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
RU2580629C1 (ru) * 2015-05-15 2016-04-10 Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ прогнозирования рецептивности эндометрия на основании оценки экспрессии и внутриклеточной локализации эзрина в эндометрии женщин с бесплодием и повторными неудачами программы эко
MD3191504T2 (ro) * 2015-06-01 2018-04-30 Nearmedic International Ltd Peptide derivate din ezrin și compozițiile farmaceutice ale acestora

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290293A (en) * 1994-06-08 1995-12-20 Rupert Donald Holms Preparation which inhibits the autoimmune response in HIV, or SLE, patients
WO1997012975A1 (en) 1995-10-02 1997-04-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services An epithelial protein and dna thereof for use in early cancer detection
US6399584B1 (en) * 1998-03-18 2002-06-04 Institute Curie Pharmaceutical composition containing ezrin mutated on tyrosine 353

Also Published As

Publication number Publication date
DE60033783D1 (de) 2007-04-19
EP1131348B1 (en) 2007-03-07
DK1131348T3 (da) 2007-07-09
PT1131348E (pt) 2007-11-19
AU7433300A (en) 2001-05-10
NZ511747A (en) 2004-03-26
GB9921881D0 (en) 1999-11-17
ES2283317T3 (es) 2007-11-01
ATE356144T1 (de) 2007-03-15
WO2001025275A9 (en) 2002-07-25
CN1327450A (zh) 2001-12-19
NO20012417L (no) 2001-07-16
BR0007158A (pt) 2001-07-31
KR20010101017A (ko) 2001-11-14
EP1131348A1 (en) 2001-09-12
PL348635A1 (en) 2002-06-03
WO2001025275A1 (en) 2001-04-12
DE60033783T2 (de) 2007-11-15
CA2348780A1 (en) 2001-04-12
HUP0104254A3 (en) 2002-05-28
GB2354241A (en) 2001-03-21
JP2003511389A (ja) 2003-03-25
US6849596B1 (en) 2005-02-01
CZ20011689A3 (cs) 2001-12-12
AU770208B2 (en) 2004-02-19
RU2215005C2 (ru) 2003-10-27
NO20012417D0 (no) 2001-05-16
EP1760090A1 (en) 2007-03-07
CN100387619C (zh) 2008-05-14
CY1106644T1 (el) 2012-01-25
ZA200103938B (en) 2002-05-15

Similar Documents

Publication Publication Date Title
DE69532760D1 (de) Mittel zur verabreichung von antigenen
DK0585943T3 (da) Opløselige ligander for CD40
EA199800946A1 (ru) Концентрированный препарат антител
AR038568A1 (es) Anticuerpos anti-a beta y su uso
ATE178053T1 (de) N2s2-chelatoren des hydrazino-typs
DE69434384D1 (de) Metalkomplexbildner
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
DE69223406D1 (de) M-Protein des Influenzavirus als antivirales Mittel
HUP0104254A2 (hu) Ezrin szabályozó/kihajtogató peptidek
DE69435059D1 (de) Immunoreaktive antigene des hepatitis e viruses
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
WO1994026903A3 (en) Human influenza virus peptides binding hla-i molecule
DK0845034T3 (da) Peptid med pronociceptive egenskaber
HUP0300997A2 (hu) A MIA-fehérje alkalmazása immunterápiában
ATE226591T1 (de) Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
EA200401390A1 (ru) N-ацетилглюкозамин-6-фосфатдеацетилаза человека, взаимодействующая с каспазой-8, и способы ее применения
NO890174L (no) Rekombinante interleukin-1alfa-polypeptider.
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
ATE255594T1 (de) Hepatitis b inhibitoren
DK0811068T3 (da) Humane DNase I varianter
DE69328488T2 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees